Update: Diasome Presents OPTI-2 Phase 2b Data at the ADA 86th Scientific Sessions

Demonstrates HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes

CareTalk Podcast: "Targeting the Root Causes of Metabolic Disease w/ Bob Geho, Founder & CEO, Diasome”

Latest Updates

News

Liver-Directed Insulin: A New Way to Reduce Hypoglycemia?

OPTI-2 Trial Results Presented at ADA on June 7th at 5pm EST

Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes

Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions